Grown Rogue International (GRUSF) Net Cash Flow Growth (1y) (2014 - 2026)
Grown Rogue International (GRUSF) Net Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -117.27% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -167.84% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -290.21% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 270.63% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -367.42% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -7.60% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 272.00% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | -986.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -986.90% |
| Mar 31, 2026 | -31.03% |
| Dec 31, 2025 | -1,292,022,235.12% |
| Jun 30, 2025 | 85.87% |
| Mar 31, 2025 | 71.84% |
| Jan 31, 2023 | 157.39% |
| Jan 31, 2022 | -48.25% |
| Oct 31, 2021 | 65,266,424.75% |
| Jul 31, 2021 | -513,162,111.51% |
| Apr 30, 2021 | 1,237.58% |
| Jan 31, 2021 | 338.18% |
| Oct 31, 2020 | 26.03% |
| Jul 31, 2020 | -66.17% |
| Apr 30, 2020 | 235.10% |
| Jan 31, 2020 | 182.12% |
| Oct 31, 2019 | -202.19% |
| Jul 31, 2019 | 224.61% |
| Apr 30, 2019 | 75.85% |
| Jan 31, 2019 | -132.41% |
| May 31, 2018 | 10.57% |